COMPARATIVE-STUDY OF CEFACLOR AND AMOXICILLIN IN TREATMENT OF URINARY-TRACT INFECTION

被引:7
作者
ROTSCHAFER, J
CROSSLEY, K
ZASKE, D
VISTE, R
机构
[1] ST PAUL RAMSEY HOSP & MED CTR,DEPT INTERNAL MED,ST PAUL,MN 55101
[2] UNIV MINNESOTA,COLL PHARM,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,SCH MED,DEPT INTERNAL MED,MINNEAPOLIS,MN 55455
[4] UNIV MINNESOTA,SCH MED,DEPT SURG,MINNEAPOLIS,MN 55455
关键词
D O I
10.1016/0090-4295(79)90489-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cefaclor or amoxicillin was given to 51 randomly assigned patients with urinary tract infections. Inclusion in the study required two pretreatment urine cultures yielding the same organism (susceptible to both antibiotics) in concentrations ≥ 105/ml. Both drugs were administered as 250 mg. orally every eight hours for ten days. Cefaclor was given to 27 patients and amoxicillin to 24. Most patients in both groups had negative urine cultures at five to nine days and four to six weeks following therapy. One patient in each group was unsuccessfully treated. Relapse or reinfection occurred with similar frequency in both treatment groups. Both antibiotics were well tolerated. Minimal inhibiting concentrations (MICs) of cefaclor, amoxicillin, cephradine, and cephalexin were determined by an agar dilution technique for the 44 available pretreatment isolates (41 Escherichia coli and 3 Proteus mirabilis). Mean MICs (μg./ml., ± SD) were 2.2 ± 1.4 for cefaclor, 4.4 ± 2.0 with amoxicillin, 8.1 ± 4.2 for cephradine, and 5.7 ± 3.0 with cephalexin. Cefaclor is highly active in vitro against those gram-negative bacteria which are commonly isolated from urine. Cefaclor is as effective as amoxicillin when administered three times daily for the treatment of urinary tract infection. © 1979.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 12 条
[1]   COMPARISON OF INVITRO ACTIVITY OF CEPHALEXIN, CEPHRADINE, AND CEFACLOR [J].
BILL, NJ ;
WASHINGTON, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (03) :470-474
[2]   PHARMACOKINETICS OF CEFACLOR IN NORMAL SUBJECTS AND PATIENTS WITH CHRONIC RENAL-FAILURE [J].
BLOCH, R ;
SZWED, JJ ;
SLOAN, RS ;
LUFT, FC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (06) :730-732
[3]  
KUNIN CM, 1974, DETECTION PREVENTION, P114
[4]   PHARMACOLOGIC STUDIES WITH CEFACLOR, A NEW ORAL CEPHALOSPORIN [J].
MEYERS, BR ;
HIRSCHMAN, SZ ;
WORMSER, G ;
GARTENBERG, G ;
SRULEVITCH, E .
JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (04) :174-179
[5]   INVITRO STUDIES WITH CEFACLOR, A NEW ORAL CEPHALOSPORIN [J].
SANDERS, CC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (04) :490-497
[6]   INVITRO ACTIVITY OF CEFACLOR, A NEW ORALLY-ADMINISTERED CEPHALOSPORIN ANTIBIOTIC [J].
SANTORO, J ;
LEVISON, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (03) :442-443
[7]   INVITRO SUSCEPTIBILITY STUDIES WITH CEFACLOR AND CEPHALEXIN [J].
SCHELD, WM ;
KORZENIOWSKI, OM ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (02) :290-292
[8]  
STEERS EDWARD, 1959, ANTIBIOT AND CHEMOTHER, V9, P307
[9]  
VALENTI AJ, 1977, YALE J BIOL MED, V50, P465
[10]  
WASHINGTON JA, 1974, LABORATORY PROCEDURE, P291